RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies
Clinical trial NCT05923541 · COMPLETED
Trial details
- NCT number
- NCT05923541
- Sponsor
- Henan Cancer Hospital
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-26
- Primary completion
- 2024-08-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.